◆ 会议时间:2022年9月1-4日 推迟至2023年
◆ 会议地点:意大利 罗马
◆ 会议简介:
2022年第7届国际头颈肿瘤学会联盟(IFHNOS)世界大会将于2022年9月1-4日在意大利罗马举行。
国际头颈肿瘤学会联盟(IFHNOS)由美国纪念斯隆-凯特琳癌症中心(MSKCC)头颈外科主任Jatin P. Shah于1987年组织建立,现已发展成为一个代表全球65个国家和区域的53个头颈肿瘤专业组织成员的全球性组织。IFHNOS的宗旨是为从事头颈部癌症领域的专家提供一个互动的平台,加强信息交流,提高知识,探索头颈癌患者诊断、治疗和康复的新方向。IFHNOS自1997年开始每4年举办一次世界大会。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com).
IFHNOS 2022
7th World Congress of the International Federation of Head and Neck Oncologic Societies
Date: 1 - 4 September, 2022
Venue: Rome, Italy
IFHNOS 2022 Topics
- RADIOTHERAPY AND RADIOTHERAPY REGIMENS IN HEAD & NECK CANCER
- IMRT AND SBRT IN HEAD & NECK CANCER
- PARTICLE THERAPY IN HEAD & NECK CANCER
- ELECTROCHEMOTHERAPY IN HEAD & NECK CANCER
- PHOTODYNAMIC THERAPY IN HEAD & NECK CANCER
- IMMUNOLOGY AND IMMUNOTHERAPY IN HEAD & NECK CANCER
- TARGET THERAPY
- RADIOSENSITIZING AGENTS
- NEW DRUGS IN HEAD & NECK ONCOLOGY
- PREVENTION OF CHEMORADIATION-INDUCED OTOTOXICITY
- TREATMENT OF HEAD & NECK RADIOTHERAPY COMPLICATIONS
- BEST SUPPORTIVE CARE
- PALLIATIVE CARE
- NUTRITIONAL MANAGEMENT AND SUPPORT IN HEAD & NECK CANCER
- RADIOMICS, GENOMICS AND METABOLOMICS IN HEAD & NECK CANCER
- MICROBIOMA AND HEAD & NECK CANCER
- LIQUID BIOPSY IN HEAD & NECK CANCER
- NEW TECHNOLOGIES IN HEAD & NECK CANCER
- TISSUE ENGINEERING IN HEAD & NECK
- ROBOTIC TOOLS IN HEAD & NECK CANCER
- TRANSPLANTATION IN THE HEAD AND NECK
- REINNERVATION SURGERY IN THE HEAD AND NECK
- INTRAOPERATIVE NERVE MONITORING
- CANCER OF THE NOSE AND PARANASAL SINUSES
- ORAL CAVITY CANCER
- OROPHARYNGEAL CANCER
- NASOPHARYNGEAL CANCER
- HYPOPHARYNGEAL CANCER
- LARYNGEAL CANCER
- CERVICAL ESOPHAGEAL CANCER
- SALIVARY GLANDS TUMORS
- THYROID (AND PARATHYROID GLANDS) CANCER
- CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
- BASAL CELL CARCINOMA OF THE HEAD AND NECK
- SKIN MELANOMA OF THE HEAD AND NECK
- MUCOSAL MELANOMA OF THE HEAD AND NECK
- SOFT TISSUE SARCOMAS OF THE HEAD AND NECK
- BONE SARCOMA OF THE HEAD AND NECK
- SYNOVIAL SARCOMA OF THE HEAD AND NECK
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|